Roll Back Malaria in Central Asia and Kazakhstan : project documents 2002-2005
World Health Organization. Regional Office for Europe. (2002). Roll Back Malaria in Central Asia and Kazakhstan : project documents 2002-2005. Copenhagen : WHO Regional Office for Europe. http://www.who.int/iris/handle/10665/107424
Gov't Doc #EUR/02/5037190
MetadataShow full item record
Showing items related by title and MeSH subject.
Roll Back Malaria partnership meeting for Central Asian Republics and Kazakhstan : report on a WHO meeting, Tashkent, Uzbekistan 8 June 1999 World Health Organization. Regional Office for Europe (EUR/ICP/CMDS 08 03 02, 1999)A meeting was held in Tashkent, Uzbekistan to establish a Roll Back Malaria partnership in the central Asian republics and Kazakhstan. The representatives of malaria surveillance and control programmes in Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan and representatives of about 30 United Nations organizations, institutions, embassies, international banks, nongovernmental organizations and foundations were present. The meeting reviewed the regional and country malaria epidemiological situation and discussed the objectives and ...
Malaria vectors and approaches to their control in malaria affected countries of the WHO European Region : the proceedings of a regional meeting on vector biology and control, Almaty, Kazakhstan, 3-5 May 2001 Unknown author (EUR/01/5027499, 2001)The purpose of the meeting was to discuss Anopheles spp., their role as malaria vectors, and their distribution in various eco-epidemiological zones of the WHO European Region. Also discussed were the susceptibility of mosquitos to insecticides and technologies for vector control, including biological methods. Entomologists and geneticists contributed knowledge on issues such as taxonomy, biology, ecology and the genetics of malaria vectors. The meeting recommended that WHO continue to support the expansion of the knowledge base and skills in ...
Unknown author (2014)The notification rate of TB cases in Kazakhstan is among the highest in the WHO European Region. WHO was requested to organize a review of the Kazakh Tuberculosis Programme, which took place from 10 to 16 May 2012. The reviewers made a number of recommendations to improve the programme. The main focus should be on: expansion of the programmatic management of drug-resistant TB, introduction and roll-out of molecular diagnosis of TB and MDR-TB, expansion of ambulatory treatment of patients, and home-based care and day-care treatment including ...